The joint association of clonal hematopoiesis of indeterminate potential and biological aging with cancer risk among 332,911 individuals

Clicks: 4
ID: 323645
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #53 of 331 articles by views in JNCI Journal of the National Cancer Institute

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 331 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP) and biological aging have been individually associated with increased cancer risks. However, their joint effect on cancer risks remains unknown. METHODS: We analyzed data from 332,911 participants at baseline in the UK Biobank. We defined CHIP as a pathogenic variant with variant allele fractions ≥2%. Biological aging was assessed by the phenotypic age acceleration (PhenoAgeAccel) and categorized as biologically younger and older. Associations of CHIP and biological aging with 25 cancers were assessed by Cox proportional hazard models. Interactions between CHIP and biological aging were tested on additive and multiplicative scales. RESULTS: CHIP was associated with higher risks of myeloid malignancies (HR 9.56, 95%CI 8.28-11.03), lung cancer (HR 1.61, 95%CI 1.42-1.82) and oesophageal cancer (HR 1.54, 95%CI 1.18-2.01). Biologically older participants had higher risks of hematologic neoplasms (HR 1.42, 95%CI 1.30-1.55) and various solid tumors compared with biologically younger participants. CHIP carriers who were biologically older had increased risks of hematologic neoplasms (HR 6.56, 95%CI 5.67-7.59) and various solid tumors compared with biologically younger participants without CHIP. The proportion of excess risk attributable to additive interaction was 40% for hematologic neoplasms and 27% for lung cancer. A significant multiplicative interaction was also observed for hematologic neoplasms (P interaction<0.001). CONCLUSION: CHIP confers substantial cancer risk, amplified when participants are biologically older. Assessing CHIP and biological aging may serve as an effective strategy for early screening and risk stratification for hematologic neoplasms and lung cancer.
Reference Key
openalex_W7172408711 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Li Wang, Kaili Sun, Siqi Lu, Yuyang Zheng, Xueqing Jia, Yanjie Zhao, Lujia Shen, Jingyun Zhang, Jing Shao, Xiao Tan, Jie Sun, Zuyun Liu
Journal JNCI Journal of the National Cancer Institute
Year 2026
DOI
10.1093/jnci/djag268
URL
https://doi.org/10.1093/jnci/djag268
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.